Medication Assisted Treatment for Couples
Offering a new government approved Suboxone maintenance program will lead to better outcomes for couples addicted to opiates. When one partner an an addicted relationship want to be clean and sober more than the other, it can pressure the other partner to stay clean. If one partner in a relationship is having cravings and wants to use heroin it can pressure the other to relapse also. Medication assisted treatment using suboxone curbs the cravings for heroin and other opiates. When a couple discharges from detox to intensive outpatient program(IOP) the y are not completely withdrawal free. There are small cravings both mental and physical that continue for 3 months. It is hard enough for a single addict to make it through this phase, but twice as hard for a couple who feed off each others thoughts and symptoms.
MAT Suboxone treatment can add the extra help to stay clean especially for couples in this period of recovery. There are not enough drug rehab centers offering this new method of substance abuse treatment. Evidence has shown that maintenance works, but the majority of professionals in the recovery field are also members of AA or NA where it is still frowned upon as not sober. Our new program will have subutex available for couples inpatient rehab program.
Married couples Who Relapse Multiple Times
Health insurance carriers, Cigna and Aetna have removed pre-certification requirements for MAT patients. This is especially helpful for couples who have relapsed multiple times. When a couple leaves detox after 7 days, their body is not fully detoxified of heroin. That process is a 6 month period.So the addict is still feeling slight symptoms and cravings. This is when most couples relapse. Staying on a low dose of suboxone helps them stay in treatment without having cravings or slight withdrawal symptoms. Northern states have been slow to allow married couples to live together while in drug rehab. In the Boston area there a few rehab facilities opening a track offering couples therapy and individual counseling.
Zubsolv was approved by the FDA in July 2013 for the detox and addiction treatment of opiate dependence. The latest formulation has high bioavailability, and a faster dissolve time, also a smaller tablet size, and a mint flavor to simplify patient adherence with treatment. Zubsolv’s use was expanded to include dosing for patients addicted to short-acting opioids like heroin in August 2015. For detox patients dependent on long-acting opioids Suboxone is recommended for induction.
Bunavail was approved by the FDA in 2014 for opioid detox and maintenance therapy. A 12-week, clinical trial of 249 patients that were converted to the buccal form of Suboxone. The test was shown to be safe and effective with less constipation than with Suboxone.
Outpatient detox treatment for heroin addiction is now possible with BMT. Physicians wishing to prescribe buprenorphine must meet the requirements outlined in the Drug Abuse Treatment Act of 2000. However, doctors can take an 8-hour training course to become certified to prescribe suboxone. Currently, each doctor is limited to 30 buprenorphine patients, but this restriction may soon be lifted.
Patients with opiate addiction often experience difficulty following existing pharmacologic treatments which reduce or eliminate opioid use. Lingerdale studied the success of buprenorphine implants over a 6-month period in patients with opiate addiction. Initial heroin detox therapy with sublingual buprenorphine-naloxone tablets preceded implant placement. Less heroin abuse was observed in patients using the buprenorphine implants compared with placebo implants. After surgery or an injury some couples become addicted to Dilaudid, a pain medication given in hospitals. Recovery from dilaidid addiction is not easy, but with 12 step meetings it is possible.